EGF and breast cancer: In order to confirm the binding of 6-gingerol to EGF receptor, we treated the breast cancer cells with recombinant human EGF (25 ng/mL) which showed an increase in the expression of phosphorylated EGFR which significantly downregulated by 6-gingerol (Figure 6B).